ClinicalTrials.gg
RecruitingNCT05468931Updated Nov 19, 2026

Prostate Stimulation for Sexual Dysfunction

An interventional study of Prostate stimulator in Sexual Dysfunction, Erectile Dysfunction and Delayed Ejaculation, sponsored by Stanford University. Recruiting at 1 site in United States. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-19.

Primary conditionErectile DysfunctionRegistry: Sexual Dysfunction, PhysiologicalReclassifiedWhy we changed it
Registry
Sexual Dysfunction, Physiological — the first condition term the registry derived for this study.
ClinicalTrials.gg
Erectile Dysfunction
Why
  1. The study's listed conditions name Erectile Dysfunction, a narrower term within Sexual Dysfunction, Physiological.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Stanford University · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Apr 2024; still recruiting 2 years 7 months later.
Updated Nov 19, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Not applicable
Ages
18 Years and older
Sex
Male
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 180 studies in Erectile Dysfunction with a site in United States — 26 open to participants now, 31 under way, 3 of them phase 3. Erectile Dysfunction · United States.

Planned enrollment
131st of 164
15 · median 75
Started
2024
with 9 others
No phase
62 of 180
16 open now
Primary completion
2027-06
later than 17 of 30 live
Registered
149th of 180
by date

Among the 180 studies in Erectile Dysfunction with a site in United States, this one is the 131st largest by planned enrollment of the 164 interventional ones that give a count, is one of 10 that started in 2024, is one of 62 with no phase, reaches primary completion later than 17 of the 30 other live ones, and was the 149th registered.

Erectile Dysfunction

702 studies on the registry are indexed under Erectile Dysfunction; 125 are open to participants now.

Browse Erectile Dysfunction studies →

Open to participants now

26 of the 180 studies in Erectile Dysfunction with a site in United States are open now. Recruiting first, the newest first:

20 more — sign in →

All 26 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 78 Erectile Dysfunction studies recruiting now, 31 (40%) set no upper age limit and 34 (44%) stop at 75 or younger; 2 take children under 18; 7 take healthy volunteers.

This study: 18 Years and older · male · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 180 studies in Erectile Dysfunction with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to use a device to stimulate the prostate with a goal of helping improve symptoms in men with sexual dysfunction.

Read the detailed description

The purpose of the study is to use a device to stimulate the prostate. The goal of this is to help men with sexual dysfunction. Sexual dysfunction can include conditions like delayed ejaculation (e.g.takes more than 21 minutes to climax) and can hopefully assist them in achieving faster time to ejaculation (e.g. closer to the median of 5.4 minutes in a "normal" individual) along with erectile dysfunction (e.g. the inability to achieve and sustain an erection).

03

Conditions studied

  • Sexual Dysfunction
  • Erectile Dysfunction
  • Delayed Ejaculation
  • Anorgasmia

Browse trials for

04

In context

Erectile Dysfunction Reclassified

702 studies on the registry are indexed under Erectile Dysfunction; 125 are open to participants now.

This study's planned enrollment of 15 is below the median of 70 across 551 interventional studies indexed under Erectile Dysfunction.

Browse Erectile Dysfunction studies →

Lead sponsor

Stanford University is the lead sponsor of 2,171 studies on the registry; 425 are open to participants now.

Of its 268 completed or terminated interventional studies of FDA-regulated products, 207 (77%) have results posted.

Compared within Erectile Dysfunction, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Sexual Dysfunction, Physiological. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Male
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Males >18 years of age suffering from sexual dysfunction

Exclusion criteria

Exclusion Criteria:

  • Individuals who have had a prostatectomy - removal of prostate
  • Inability to operate the device for any reason
  • Females
  • Males \<18 years of age
06

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
15 participants (estimated)

Study arms

  • Experimental
    Prostate stimulation device arm

    Participants will be asked to use our prostate stimulation device.

    Device: Prostate stimulator

Interventions

  • DeviceProstate stimulator

    Prostate stimulation device for sexual dysfunction

07

What researchers measure

Primary outcomes

  1. change in modified International Index of Erectile Dysfunction score

    score 0 to 30 with higher score meaning better erectile function

    Time frame: baseline and up to 1 month post-baseline

08

Study locations

1 of 1 sites recruiting
09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2024 (actual). Primary completion is estimated for Jun 2027, 37 months after the start.

Of 115 non-industry interventional studies with no phase under Erectile Dysfunction, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 52. This study's planned 37 months is above that.

Counting every sponsor, half of 137 studies reached it within 32 months; a quarter within 14 and three quarters within 52.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 19, 2026: primary completion Jun 2026 → Jun 2027 and completion Jun 2026 → Jun 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jul 18, 2022
First posted
Jul 21, 2022
StartActual
Apr 18, 2024
Primary completionEst.
Jun 1, 2027was Jun 2026
CompletionEst.
Jun 1, 2027was Jun 2026
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Jun 1, 2026→Jun 1, 2027
Nov 19, 2026
Study completion
Jun 1, 2026→Jun 1, 2027
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    Primary completion Jun 1, 2026→Jun 1, 2027
    Study completion Jun 1, 2026→Jun 1, 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05468931
Responsible party
Michael Eisenberg (Study Principal Investigator, Stanford University) — Principal investigator
First posted
Jul 21, 2022
Start date
Apr 18, 2024
Primary completion
Jun 1, 2027 (estimated)
Completion
Jun 1, 2027 (estimated)
Last update
Nov 19, 2026

Study contacts

Satvir Basran
Contact
sbasran@stanford.edu
650-723-0948
Michael Eisenberg, M.D.
principal investigator · Stanford University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion